CIA
BLUE

CSat Investment Advisory’s bluebird bio BLUE Stock Holding History

CSat Investment Advisory’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13
Closed -$9K – 577
2020
Q3 		$9K Buy
13
+1
+8% +$780 ﹤0.01% 1053
2020
Q2 		$9K Sell
12
-19
-61% -$14.3K ﹤0.01% 1053
2020
Q1 		$18K Buy
31
+6
+24% +$5.85K ﹤0.01% 742
2019
Q4 		$29K Buy
25
+2
+9% +$2.17K 0.01% 693
2019
Q3 		$27K Buy
23
+4
+21% +$6.11K 0.01% 648
2019
Q2 		$31K Buy
+19
New +$32.9K 0.01% 641

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CSat Investment Advisory's BLUE Position: Q4 2020 in Review

CSat Investment Advisory sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 13 shares — an estimated $9K sold.

CSat Investment Advisory first reported a position in BLUE in Q2 2019 and held it in 6 quarters. The position peaked at $31K in Q2 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • CSat Investment Advisory reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 13 bluebird bio shares in Q4 2020, an estimated $9K.
  • CSat Investment Advisory first reported a position in bluebird bio in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's bluebird bio position peaked at $31K in Q2 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.